Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1136/thoraxjnl-2015-206854 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Surgical Fixation of Flail Chest Injuries: Reduction and Fixation Options, Tips and Tricks.
J Orthop Trauma
December 2024
OhioHealth, Grant Medical Center, Columbus, OH.
Modern techniques of rib fracture fixation surgery follow the AO principles of fracture reduction, fixation, and appropriate soft tissue handling. Fixation techniques can be performed using anatomic reduction and rigid fixation, or bridge plate fixation for comminuted fractures. Anatomic and nonanatomic plates can be used, although titanium precontoured locking plates are the most commonly used.
View Article and Find Full Text PDFA case of intrathoracic extramedullary hematopoiesis-associated pleural effusion in a beta-thalassemia intermedia patient and a short literature review.
SAGE Open Med Case Rep
December 2024
First Department of Internal Medicine, "Tzaneio" General Hospital of Piraeus, Piraeus, Greece.
Extramedullary hematopoiesis is a phenomenon that occurs in conditions of ineffective bone marrow function. In the context of thalassemias, extramedullary hematopoiesis is more frequently observed in beta-thalassemia intermedia patients, with thoracic paravertebral extramedullary hematopoiesis being relatively common. However, extramedullary hematopoiesis-related pleural effusion is a rare occurrence.
View Article and Find Full Text PDFMultiple intrathoracic extramedullary haematopoiesis as visualised on medical thoracoscopy.
Thorax
September 2024
Department of Respiratory Medicine, Hospital Queen Elizabeth, Kota Kinabalu, Sabah, Malaysia.
Luspatercept's use in a patient with transfusion-dependent beta-thalassemia and intrathoracic extramedullary hematopoiesis (EMH).
Clin Case Rep
May 2024
Hematology department Hamad Medical Corporation Doha Qatar.
Article Synopsis
- This case report and literature review focus on using luspatercept, a new treatment, for a beta-thalassemia patient with extramedullary hematopoiesis (EMH) despite its associated risks.
- The patient had a high risk for complications due to prior medical issues, but luspatercept successfully improved hemoglobin levels and reduced iron overload without any notable adverse effects.
- The report emphasizes the need for further research on luspatercept's safety and efficacy, particularly in patients with EMH, as existing literature shows potential risks like EMH expansion.
A Rare Cause of Giant Intrathoracic Mass in a Woman with Sickle Cell Disease: Extramedullary Hematopoiesis.
Turk J Haematol
August 2024
University of Chicago Medicine, Department of Radiology, Chicago, USA
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!